# Unlocking the potential of community pharmacies to address hypertension in South Asia: the COPE-BP programme

**Authors:** Saima Afaq, Helen Elsey, Mohammad Ismail, Khaleda Islam, Rumana Huque, Simon Walker, Catherine Hewitt, Kamran Siddiqi, Aziz Sheikh, Cath Jackson, Cath Jackson, Joao Porto de Albuquerque, Shaista Rasool, Abdul Jalil Khan, Zia ul Haq, Naomi Gibbs, Mehreen Faisal, Faiza Aslam, Waqas Ahmad, Enayet Hussain, Saira Bokhari

PMC · DOI: 10.7189/jogh.16.03005 · Journal of Global Health · 2026-02-20

## TL;DR

This paper explores using community pharmacies in South Asia to better manage hypertension, aiming to improve care for millions of affected adults.

## Contribution

The study introduces a novel program to evaluate community pharmacists' role in hypertension care in Bangladesh and Pakistan.

## Key findings

- Community pharmacies are a widely accessed yet underutilized resource for hypertension management in South Asia.
- The COPE-BP program aims to assess the effectiveness and cost-effectiveness of integrating pharmacists into hypertension care.
- The initiative seeks to create a scalable model for involving non-traditional providers in national health strategies.

## Abstract

Hypertension is a leading contributor to cardiovascular disease in South Asia, affecting over 40% of adults, of whom most remain undiagnosed or poorly managed. Despite urgent healthcare needs, the already overstretched public primary care systems in low- and middle-income countries, particularly in rapidly growing urban areas, are falling short. Community pharmacies, often the first point of contact for low-income urban residents, represent an opportunity for delivering frontline chronic disease care. The Community-Pharmacies managing hypertension: intervention development and Evaluation in Bangladesh and Pakistan (COPE-BP) programme aims to investigate whether these widely accessed yet under-evaluated community pharmacists are effective and cost-effective, and assess whether the COPE-BP intervention can be successfully integrated into hypertension care pathways in Bangladesh and Pakistan. Beyond evaluating clinical and economic outcomes, COPE-BP seeks to reframe the role of semi-formal providers, including community pharmacies, which are key actors in primary care delivery. Through a stepwise programme encompassing intervention development, a multicentre clinical trial, implementation research, and policy engagement, COPE-BP aims to provide a scalable model for integrating non-traditional providers into national health strategies. In doing so, COPE-BP will help strengthen inclusive, people-centred health systems in LMICs.

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Diseases:** non (MESH:C580335), chronic disease (MESH:D002908), LIURs (MESH:D009800), NCDs (MESH:D000073296), Hypertension (MESH:D006973), VISION (MESH:D014786), deaths (MESH:D003643), BP (MESH:D007022), disease (MESH:D004194), CVD (MESH:D002318)
- **Chemicals:** COPE (MESH:C094992), BP (MESH:C038809)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922466/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922466/full.md

---
Source: https://tomesphere.com/paper/PMC12922466